Saha, S., Gerdtham, U., Sjödahl, G., Häggström, C., Catto, J. W. F., Kelly, J. D., . . . Lund University, F. o. M. (2025). Cost-effectiveness of de-escalated molecular subtype dependent use of neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer in a Swedish setting. Frontiers in Oncology, 15, 1-10. https://doi.org/10.3389/fonc.2025.1556881
Chicago-referens (17:e uppl.)Saha, Sanjib, et al. "Cost-effectiveness of De-escalated Molecular Subtype Dependent Use of Neoadjuvant Chemotherapy in Patients with Muscle-invasive Bladder Cancer in a Swedish Setting." Frontiers in Oncology 15 (2025): 1-10. https://doi.org/10.3389/fonc.2025.1556881.
MLA-referens (9:e uppl.)Saha, Sanjib, et al. "Cost-effectiveness of De-escalated Molecular Subtype Dependent Use of Neoadjuvant Chemotherapy in Patients with Muscle-invasive Bladder Cancer in a Swedish Setting." Frontiers in Oncology, vol. 15, 2025, pp. 1-10, https://doi.org/10.3389/fonc.2025.1556881.
